Lung neoplasm malignant Clinical Trials
Conditions / Lung neoplasm malignant
Delta Trials records 22 clinical trials for Lung neoplasm malignant in its publicly accessible dataset. From the full dataset, 8 actively seeking eligible participants and 6 trials have reached completion. This research is conducted across 71 study locations around the world. An additional 8 trials are active but not currently open for enrollment. Since 2020, 3 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
22
Total Trials
8
Recruiting
6
Completed
8
Other Active
3
Terminated since 2020
71
Study Locations
Browse by location (71 total)
- New York, United States 3 trialsAll trials in New York, United States
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Houston, United States 2 trialsAll trials in Houston, United States
- Warsaw, Poland 2 trialsAll trials in Warsaw, Poland
- Taichung, Taiwan 2 trialsAll trials in Taichung, Taiwan
- Philadelphia, United States 2 trialsAll trials in Philadelphia, United States
- Athens, Greece 2 trialsAll trials in Athens, Greece
- Athens, Greece 2 trialsAll trials in Athens, Greece
- Barcelona, Spain 2 trialsAll trials in Barcelona, Spain
- Shanghai, China 2 trialsAll trials in Shanghai, China
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Milan, Italy 2 trialsAll trials in Milan, Italy
- Fairfax, United States 2 trialsAll trials in Fairfax, United States
- Vienna, Austria 2 trialsAll trials in Vienna, Austria
- Taoyuan District, Taiwan 1 trialAll trials in Taoyuan District, Taiwan
- Győr, Hungary 1 trialAll trials in Győr, Hungary
- Washington D.c, United States 1 trialAll trials in Washington D.c, United States
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States
- Pinehurst, United States 1 trialAll trials in Pinehurst, United States
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium